[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate

C53H101NO5 — CID 138244012

IUPAC[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate
SMILESCCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC
InChIInChI=1S/C53H101NO5/c1-3-5-7-9-11-13-15-17-18-19-20-22-27-31-35-39-43-47-53(58)59-48-44-40-36-32-28-24-23-26-30-34-38-42-46-52(57)54-50(49-55)51(56)45-41-37-33-29-25-21-16-14-12-10-8-6-4-2/h11,13,17-18,50-51,55-56H,3-10,12,14-16,19-49H2,1-2H3,(H,54,57)/b13-11-,18-17-
InChIKeyQHZRWZKCOPDBFE-BCTRXSSUSA-N
MW832.39 g/mol
LogP15.51
Rot. Bonds48

About [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate

[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate (PubChem CID 138244012) has the molecular formula C53H101NO5 and a molecular weight of 832.39 g/mol. Its IUPAC name is [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate.

Molecular Properties

Compound Name[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate
PubChem CID138244012
Molecular FormulaC53H101NO5
Molecular Weight832.39 g/mol
Exact Mass831.77
IUPAC Name[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate
SMILESCCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC
InChIInChI=1S/C53H101NO5/c1-3-5-7-9-11-13-15-17-18-19-20-22-27-31-35-39-43-47-53(58)59-48-44-40-36-32-28-24-23-26-30-34-38-42-46-52(57)54-50(49-55)51(56)45-41-37-33-29-25-21-16-14-12-10-8-6-4-2/h11,13,17-18,50-51,55-56H,3-10,12,14-16,19-49H2,1-2H3,(H,54,57)/b13-11-,18-17-
InChIKeyQHZRWZKCOPDBFE-BCTRXSSUSA-N
XLogP15.51
TPSA95.86 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds48
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500832.39
LogP ≤ 515.51
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate?
The IUPAC name of [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate (CID 138244012) is [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate.
What is the SMILES notation for [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate?
The canonical SMILES for [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate is CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC.
What is the InChIKey of [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate?
The InChIKey is QHZRWZKCOPDBFE-BCTRXSSUSA-N. The full InChI is InChI=1S/C53H101NO5/c1-3-5-7-9-11-13-15-17-18-19-20-22-27-31-35-39-43-47-53(58)59-48-44-40-36-32-28-24-23-26-30-34-38-42-46-52(57)54-50(49-55)51(56)45-41-37-33-29-25-21-16-14-12-10-8-6-4-2/h11,13,17-18,50-51,55-56H,3-10,12,14-16,19-49H2,1-2H3,(H,54,57)/b13-11-,18-17-.
What are the key properties of [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate?
[15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate has a molecular weight of 832.39 g/mol, XLogP of 15.51, 48 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [15-(1,3-dihydroxyoctadecan-2-ylamino)-15-oxopentadecyl] (11Z,14Z)-icosa-11,14-dienoate is sourced from PubChem (CID 138244012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).